Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $298.71 | 3 | 56.0% |
| Food and Beverage | $234.51 | 5 | 44.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $302.50 | 3 | $0 (2024) |
| Medtronic MiniMed, Inc. | $135.41 | 1 | $0 (2018) |
| Amryt Pharma Holdings Ltd | $55.35 | 1 | $0 (2022) |
| Novo Nordisk Inc | $16.60 | 1 | $0 (2017) |
| Xeris Pharmaceuticals, Inc. | $12.33 | 1 | $0 (2022) |
| EISAI INC. | $11.03 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.12 | 1 | Abbott Laboratories ($16.12) |
| 2022 | $67.68 | 2 | Amryt Pharma Holdings Ltd ($55.35) |
| 2020 | $99.98 | 1 | Abbott Laboratories ($99.98) |
| 2019 | $11.03 | 1 | EISAI INC. ($11.03) |
| 2018 | $321.81 | 2 | Abbott Laboratories ($186.40) |
| 2017 | $16.60 | 1 | Novo Nordisk Inc ($16.60) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes Care | ||||||
| 10/07/2022 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $55.35 | General |
| Category: Endocrinology | ||||||
| 05/23/2022 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Education | In-kind items and services | $12.33 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/27/2020 | Abbott Laboratories | FreeStyle Lite system (Device) | Education | In-kind items and services | $99.98 | General |
| Category: Diabetes Care | ||||||
| 02/13/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $11.03 | General |
| Category: Oncology | ||||||
| 06/08/2018 | Abbott Laboratories | FreeStyle Freedom Lite system (Device), FreeStyle InsuLinx system, FreeStyle Lite system | Education | In-kind items and services | $186.40 | General |
| Category: Diabetes Care | ||||||
| 01/17/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $135.41 | General |
| Category: Durable Pump | ||||||
| 09/11/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 212 | 301 | $135,678 | $21,195 |
| 2022 | 4 | 227 | 299 | $115,834 | $20,950 |
| 2021 | 5 | 269 | 350 | $117,734 | $24,699 |
| 2020 | 6 | 321 | 362 | $96,187 | $17,201 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 224 | $92,716 | $14,979 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 33 | $18,908 | $3,283 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $19,944 | $2,562 | 12.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 11 | 15 | $4,110 | $371.28 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 205 | $75,839 | $13,768 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 61 | $31,982 | $5,888 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $4,278 | $885.86 | 20.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 14 | 15 | $3,735 | $407.61 | 10.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 153 | $55,961 | $11,154 | 19.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 64 | $32,984 | $7,096 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 64 | $15,080 | $2,706 | 17.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 28 | $6,944 | $1,973 | 28.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 30 | 41 | $6,765 | $1,771 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 144 | $51,646 | $7,821 | 15.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 48 | 56 | $13,704 | $3,462 | 25.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 61 | 63 | $10,135 | $2,491 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 48 | $11,135 | $1,796 | 16.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $6,576 | $870.83 | 13.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 36 | 39 | $2,991 | $759.09 | 25.4% |
About Dr. Dina Serhal, MD
Dr. Dina Serhal, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467528745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dina Serhal, MD has received a total of $533.22 in payments from pharmaceutical and medical device companies, with $16.12 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Education" ($298.71).
As a Medicare-enrolled provider, Serhal has provided services to 1,029 Medicare beneficiaries, totaling 1,312 services with total Medicare billing of $84,045. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Cleveland, OH
- Active Since 11/28/2006
- Last Updated 02/04/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1467528745
Products in Payments
- FreeStyle Freedom Lite system (Device) $186.40
- Minimed 670G System (Device) $135.41
- FreeStyle Lite system (Device) $99.98
- MYCAPSSA (Drug) $55.35
- FREESTYLE LIBRE 3 (Device) $16.12
- RECORLEV (Drug) $12.33
- Lenvima (Drug) $11.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Cleveland
Kevin Pantalone, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Adi Mehta, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $216,001
Dr. Allan Kennedy, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,447
Christian Nasr, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $152,638
Dr. Bartolome Burguera, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $92,204
Robert Zimmerman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $58,659